You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent childhood soft tissue sarcoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Completed
  • Recurrent Childhood Acute Myeloid Leukemia
  • +13 more
    • Miami, Florida
      Nicklaus Children's Hospital
    Jan 18, 2023

    Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

    Recruiting
    • Recurrent Childhood Acute Myeloid Leukemia
    • +17 more
      • Miami, Florida
        Nicklaus Children's Hospital
      May 13, 2023

      Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

      Active, not recruiting
      • Advanced Malignant Neoplasm
      • +38 more
      • Bevacizumab
      • +5 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 18, 2022

      Metastatic Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma Trial in Hannover (Durvalumab and Tremelimumab,

      Completed
      • Metastatic Adult Soft Tissue Sarcoma
      • Recurrent Adult Soft Tissue Sarcoma
      • Hannover, Germany
        Medizinische Hochschule Hannover
      Jan 18, 2023

      Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)

      Active, not recruiting
      • Sarcoma, Soft Tissue
      • Changsha, Hunan, China
        Xiangya Hospital Central South University
      Oct 29, 2023

      Soft Tissue Sarcoma Trial in Palo Alto (External Beam Radiotherapy)

      Recruiting
      • Soft Tissue Sarcoma
      • External Beam Radiotherapy
      • Palo Alto, California
        Stanford University
      Oct 11, 2023

      Soft Tissue Sarcoma Adult Trial (Surufatinib)

      Not yet recruiting
      • Soft Tissue Sarcoma Adult
      • (no location specified)
      Oct 29, 2023

      Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma

      Recruiting
      • Pediatric Soft Tissue Sarcoma
      • detection and monitoring of cirulating tumor DNA
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Mar 20, 2023

      Sarcoma,Soft Tissue, Brachytherapy, Poly(ADP-ribose) Polymerase Inhibitors Trial in Guangzhou (Fluzoparib, Radioactive particle

      Recruiting
      • Sarcoma,Soft Tissue
      • +2 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      May 30, 2023

      Osteosarcoma, Soft Tissue Sarcoma Trial in Shanghai (NK510)

      Recruiting
      • Osteosarcoma
      • Soft Tissue Sarcoma
      • Shanghai, China
        Shanghai General Hospital
      Oct 31, 2023

      Soft Tissue Sarcoma Trial (Cadonilimab)

      Not yet recruiting
      • Soft Tissue Sarcoma
      • Cadonilimab
      • (no location specified)
      Dec 9, 2022

      Sarcoma Trial in Chapel Hill (GRID therapy)

      Not yet recruiting
      • Sarcoma
      • GRID therapy
      • Chapel Hill, North Carolina
        University of North Carolina at Chapel Hill, Department of Radia
      Oct 5, 2023

      Clear Cell Sarcoma of Soft Tissue Trial in Wuhan (18F-PFPN)

      Recruiting
      • Clear Cell Sarcoma of Soft Tissue
      • Wuhan, Hubei, China
        China, Hubei Province
      Jul 19, 2023

      Advanced Soft-tissue Sarcoma Trial in Shenzhen (NY-ESO-1 TCR-T)

      Recruiting
      • Advanced Soft-tissue Sarcoma
      • NY-ESO-1 TCR-T
      • Shenzhen, Guangdong, China
        Li Yu
      Nov 17, 2022

      Soft Tissue Sarcoma, Sts, Sarcoma,Soft Tissue Trial in Saint Louis (ADI PEG20, Ifosfamide, Radiotherapy)

      Not yet recruiting
      • Soft Tissue Sarcoma
      • +2 more
      • ADI PEG20
      • +3 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Apr 2, 2023

      Soft Tissue Sarcoma Trial (Candonilimab)

      Not yet recruiting
      • Soft Tissue Sarcoma
      • (no location specified)
      Jun 22, 2023

      Advanced Soft-tissue Sarcoma Trial (Lurbinectedin)

      Not yet recruiting
      • Advanced Soft-tissue Sarcoma
      • (no location specified)
      May 26, 2023

      Sarcoma, Soft Tissue Trial in Berlin, Munich (DPPG2-TSL-DOX)

      Recruiting
      • Sarcoma, Soft Tissue
      • Berlin, Germany
      • +1 more
      May 12, 2023

      Locally Advanced Soft Tissue Sarcoma, Recurrent Soft Tissue Sarcoma Trial in Barcelona, Madrid, Valencia (CEB-01 membrane loaded

      Recruiting
      • Locally Advanced Soft Tissue Sarcoma
      • Recurrent Soft Tissue Sarcoma
      • CEB-01 membrane loaded with SN-38
      • Barcelona, Cataluña, Spain
      • +4 more
      Jul 26, 2022

      Soft Tissue Sarcoma Trial in New York (Tigilanol Tiglate)

      Not yet recruiting
      • Soft Tissue Sarcoma
      • Tigilanol Tiglate
      • New York, New York
        Memorial Sloan Kettering Cancer Centre
      Mar 2, 2023

      Soft Tissue Sarcoma Trial in Zhengzhou (Anrotinib HCl combined with adriamycin)

      Recruiting
      • Soft Tissue Sarcoma
      • Anrotinib hydrochloride combined with adriamycin
      • Zhengzhou, Henan, China
        Henan Cancer Hospital
      Feb 27, 2023

      High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Surufatinib, Sintilimab, Radiotherapy)

      Recruiting
      • High-Risk Localized Soft Tissue Sarcoma
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Apr 20, 2023

      Soft Tissue Sarcoma Trial in Zhengzhou (Piamprimab (AK105))

      Not yet recruiting
      • Soft Tissue Sarcoma
      • Piamprimab (AK105)
      • Zhengzhou, Henan, China
        Henan Cancer Hospital
      Jan 30, 2023

      Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma Trial (fruquintinib, Envafolimab)

      Not yet recruiting
      • Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma
      • (no location specified)
      Jul 10, 2023

      Immunotherapy and Targeted Therapy for Advanced Soft Tissue

      Recruiting
      • Advanced Soft Tissue Sarcoma
        • Beijing, Beijing, China
          Department of Medical Oncology, Peking Union Medical College Hos
        Sep 25, 2023